Required criteria |
Chronic nonmalignant lymphadenopathy and/or splenomegaly |
Increased peripheral CD3+TCRαβ+CD4−CD8− (DNT) cells |
Lymphocyte apoptosis defect |
Supporting criteria |
Family history of ALPS |
Characteristic histopathology |
Autoimmune manifestations |